Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Furthermore, if the P/E ratio were to mean-revert to a modest 12x on our 2025 EPS estimate of ~$3, the implied stock price would be $36
Unlike supplement companies that sell the same formula to everyone, PlexusDx uses genetic data and clinical assessment to personalize GLP-1 dosing and selection
Njomos experience allows her to tailor treatment plans based on individual needs, adjusting dosages as necessary to maximize appetite suppression
For patients continuing GLP-1 medications long-term, a phased approach often works best
US$ 22.13
US$ 29.80
US$ 25.52
US$ 24.51
